Mill1 Inhibitors

Mill1 inhibitors, referring to chemicals that can inhibit the function or expression of MHC I like leukocyte 1 (Mill1), are varied in their mechanisms of action. These compounds typically influence the processing and presentation of antigens on the cell surface, which is a critical step in the immune response where Mill1 is presumed to participate. The inhibitors listed above operate through mechanisms such as modulation of immune response, interference in antigen presentation, inhibition of proteasome activity, disruption of cytoskeletal and intracellular trafficking processes, modulation of endosomal/lysosomal pH, and inhibition of various proteases.

These chemical compounds, while not directly targeting Mill1, affect the processes and pathways that are believed to be associated with the protein's function. For example, curcumin can reduce the expression of MHC class I molecules, affecting the surface presentation of antigens. EGCG and genistein can impair the expression and functionality of MHC class I molecules through their actions on cell surface expression and signal transduction, respectively. Proteasome inhibitors like disulfiram, lactacystin, and MG132 prevent the breakdown of proteins into peptides that would normally be presented by MHC class I molecules, thereby potentially inhibiting Mill1-associated processes. Brefeldin A and monensin interfere with the intracellular transport and glycosylation of MHC class I molecules, while colchicine and withaferin A disrupt the cytoskeleton, further affecting the trafficking and surface expression of these molecules. Lastly, chloroquine and leupeptin alter the antigen processing pathways by affecting the intracellular compartments' pH and inhibiting certain proteases, which could influence the function of Mill1.